Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
Abstract Reduced taste sensitivity to 6-n-propylthiouracil (PROP), a genetic trait regarded as a general index for oral chemosensory perception, has been associated with a calorie-rich food preference and lower circulating endocannabinoid levels in participants with normal weight (NW), which suggest...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/044e5aee3e6c42f39187e7b686e46d24 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:044e5aee3e6c42f39187e7b686e46d24 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:044e5aee3e6c42f39187e7b686e46d242021-12-02T11:52:59ZParticipants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids10.1038/s41598-017-01562-12045-2322https://doaj.org/article/044e5aee3e6c42f39187e7b686e46d242017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01562-1https://doaj.org/toc/2045-2322Abstract Reduced taste sensitivity to 6-n-propylthiouracil (PROP), a genetic trait regarded as a general index for oral chemosensory perception, has been associated with a calorie-rich food preference and lower circulating endocannabinoid levels in participants with normal weight (NW), which suggests an adaptive mechanism to maintain a lean phenotype. In this study, we assessed whether participants with obesity (OB) show different patterns of plasma endocannabinoids and lipid metabolism biomarkers from those of NW, with further categorization based on their PROP sensitivity. NW and OB were classified by their PROP taster status as non-tasters (NT), medium-tasters (MT) and supertasters (ST). The blood samples were analysed for plasma endocannabinoids, nonesterified fatty acids (NEFA) and retinol, which have been associated to metabolic syndrome. In OB, we found a higher BMI and lower circulating endocannabinoids in ST vs. OB NT. However, OB ST showed lower circulating NEFA and retinol levels, which suggested a more favourable lipid metabolism and body fat distribution than those of OB NT. We confirmed lower plasma endocannabinoid levels in NW NT than in NW ST. These data suggest that PROP taste sensitivity determines metabolic changes and ultimately body mass composition differently in OB and NW.Gianfranca CartaMelania MelisStefano PintusPaolo PintusCarla A. PirasLaura MureddaDaniela DemurtasVincenzo Di MarzoSebastiano BanniIole Tomassini BarbarossaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Gianfranca Carta Melania Melis Stefano Pintus Paolo Pintus Carla A. Piras Laura Muredda Daniela Demurtas Vincenzo Di Marzo Sebastiano Banni Iole Tomassini Barbarossa Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids |
description |
Abstract Reduced taste sensitivity to 6-n-propylthiouracil (PROP), a genetic trait regarded as a general index for oral chemosensory perception, has been associated with a calorie-rich food preference and lower circulating endocannabinoid levels in participants with normal weight (NW), which suggests an adaptive mechanism to maintain a lean phenotype. In this study, we assessed whether participants with obesity (OB) show different patterns of plasma endocannabinoids and lipid metabolism biomarkers from those of NW, with further categorization based on their PROP sensitivity. NW and OB were classified by their PROP taster status as non-tasters (NT), medium-tasters (MT) and supertasters (ST). The blood samples were analysed for plasma endocannabinoids, nonesterified fatty acids (NEFA) and retinol, which have been associated to metabolic syndrome. In OB, we found a higher BMI and lower circulating endocannabinoids in ST vs. OB NT. However, OB ST showed lower circulating NEFA and retinol levels, which suggested a more favourable lipid metabolism and body fat distribution than those of OB NT. We confirmed lower plasma endocannabinoid levels in NW NT than in NW ST. These data suggest that PROP taste sensitivity determines metabolic changes and ultimately body mass composition differently in OB and NW. |
format |
article |
author |
Gianfranca Carta Melania Melis Stefano Pintus Paolo Pintus Carla A. Piras Laura Muredda Daniela Demurtas Vincenzo Di Marzo Sebastiano Banni Iole Tomassini Barbarossa |
author_facet |
Gianfranca Carta Melania Melis Stefano Pintus Paolo Pintus Carla A. Piras Laura Muredda Daniela Demurtas Vincenzo Di Marzo Sebastiano Banni Iole Tomassini Barbarossa |
author_sort |
Gianfranca Carta |
title |
Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids |
title_short |
Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids |
title_full |
Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids |
title_fullStr |
Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids |
title_full_unstemmed |
Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids |
title_sort |
participants with normal weight or with obesity show different relationships of 6-n-propylthiouracil (prop) taster status with bmi and plasma endocannabinoids |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/044e5aee3e6c42f39187e7b686e46d24 |
work_keys_str_mv |
AT gianfrancacarta participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT melaniamelis participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT stefanopintus participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT paolopintus participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT carlaapiras participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT lauramuredda participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT danielademurtas participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT vincenzodimarzo participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT sebastianobanni participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids AT ioletomassinibarbarossa participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids |
_version_ |
1718394906318209024 |